XKRX
014680
Market cap1.82bUSD
Jul 10, Last price
248,500.00KRW
1D
2.26%
1Q
-10.29%
Jan 2017
198.32%
Name
Hansol Chemical Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hansol Chemical Co., Ltd., along with its subsidiaries, operates primarily in South Korea as a producer and supplier of a broad spectrum of chemicals. Its extensive fine chemical portfolio includes hydrogen peroxide, a versatile bleaching agent used across various sectors including semiconductors, LCDs, paper pulp, textiles, and environmental remediation. For industrial wastewater treatment, the company provides emulsion-type polyacrylamide and organic coagulants, and supplies retention agents, polyamine, and micro-capsules essential for papermaking. Its synthetic latex product line features HITEX, utilized in paper coatings, carpet backing, and construction; Bio-SBL, a grafting copolymer for paper surface sizing; HanCellymer, an aqua binder for lithium-ion batteries; and Hansphere, which improves the gloss and opacity of coated papers. Further fine chemical offerings include sodium dithionite/sodium hydrosulfite, a key bleaching agent for pulp, textiles, and leather, as well as benzoyl peroxide, which functions as both a polymerization initiator and a bleaching agent for the chemical and food sectors. Within its electronic materials division, Hansol Chemical offers UV-curable optical clear resins for tablet PCs and smartphones, along with conformal coatings designed to safeguard FPD panel circuits. Other electronic offerings include specialized cleaning solutions for coating equipment, black side sealing resins to prevent light leakage from OLED panels, and thermal interface materials crucial for FPCB chips. Additionally, the company develops thin film materials specifically for the semiconductor industry. Established in 1980, the firm operated as Hansol Chemience Co., Ltd. until its renaming to Hansol Chemical Co., Ltd. in March 2004. Its headquarters are situated in Seoul, South Korea.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||